Skip to main content
Erschienen in: Surgery Today 11/2020

25.05.2020 | Original Article

D2 lymph node dissection confers little benefit on the overall survival of older patients with resectable gastric cancer: a propensity score-matching analysis of a multi-institutional dataset

verfasst von: Takahiro Shinozuka, Mitsuro Kanda, Seiji Ito, Yoshinari Mochizuki, Hitoshi Teramoto, Kiyoshi Ishigure, Toshifumi Murai, Takahiro Asada, Akiharu Ishiyama, Hidenobu Matsushita, Chie Tanaka, Daisuke Kobayashi, Michitaka Fujiwara, Kenta Murotani, Yasuhiro Kodera

Erschienen in: Surgery Today | Ausgabe 11/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Aging societies comprise an increasing number of elderly gastric cancer (GC) patients. We herein attempted to determine whether D2 lymphadenectomy is beneficial for older GC patients.

Methods

We retrospectively analyzed a multi-institutional dataset including 3484 patients who received surgical resection for GC. For the analysis, we selected patients aged ≥ 80 years who were clinically diagnosed with T1N + or T2-4 GC. To balance the essential variables including the type of gastrectomy and the stage of progression, propensity score matching was conducted, and we compared the background clinical factors and postoperative outcomes of the patients allocated to the D2 (n = 87) and non-D2 (n = 87) dissection groups.

Results

The D2 group had significantly longer operative times, more blood loss, and more retrieved lymph nodes (median 32 vs 24, P < 0.001) than the non-D2 group. The D2 group had a greater incidence of intra-abdominal abscesses (grade ≥ II in the Clavien–Dindo classification) than the non-D2 group (3.5% vs 0%, P = 0.040). The overall disease-specific and relapse-free survival rates of the D2 group tended to be poorer than those of the non-D2 group (hazard ratios 1.49, 1.70 and 1.14, respectively).

Conclusions

D2 lymphadenectomy for older patients with GC conferred little benefit regarding overall survival despite an occurrence of increased complication rates.
Literatur
3.
Zurück zum Zitat Endo S, Shimizu Y, Ikenaga M, Ohta K, Yamada T. Survival benefit of gastrectomy for gastric cancer in patients %3e/=85 years old: a retrospective propensity score-matched analysis. Surgery. 2017;161(4):984–94.CrossRef Endo S, Shimizu Y, Ikenaga M, Ohta K, Yamada T. Survival benefit of gastrectomy for gastric cancer in patients %3e/=85 years old: a retrospective propensity score-matched analysis. Surgery. 2017;161(4):984–94.CrossRef
4.
Zurück zum Zitat Mengardo V, Cormack OM, Weindelmayer J, Chaudry A, Bencivenga M, Giacopuzzi S, et al. Multicenter study of presentation, management, and postoperative and long-term outcomes of septegenerians and octogenerians undergoing gastrectomy for gastric cancer. Ann Surg Oncol. 2018;25(8):2374–82.CrossRef Mengardo V, Cormack OM, Weindelmayer J, Chaudry A, Bencivenga M, Giacopuzzi S, et al. Multicenter study of presentation, management, and postoperative and long-term outcomes of septegenerians and octogenerians undergoing gastrectomy for gastric cancer. Ann Surg Oncol. 2018;25(8):2374–82.CrossRef
5.
Zurück zum Zitat Hikage M, Tokunaga M, Makuuchi R, Irino T, Tanizawa Y, Bando E, et al. Surgical outcomes after gastrectomy in very elderly patients with gastric cancer. Surg Today. 2018;48(8):773–82.CrossRef Hikage M, Tokunaga M, Makuuchi R, Irino T, Tanizawa Y, Bando E, et al. Surgical outcomes after gastrectomy in very elderly patients with gastric cancer. Surg Today. 2018;48(8):773–82.CrossRef
6.
Zurück zum Zitat Cho GS, Kim W, Kim HH, Ryu SW, Kim MC, Ryu SY, et al. Multicentre study of the safety of laparoscopic subtotal gastrectomy for gastric cancer in the elderly. Br J Surg. 2009;96(12):1437–42.CrossRef Cho GS, Kim W, Kim HH, Ryu SW, Kim MC, Ryu SY, et al. Multicentre study of the safety of laparoscopic subtotal gastrectomy for gastric cancer in the elderly. Br J Surg. 2009;96(12):1437–42.CrossRef
7.
Zurück zum Zitat Lee JH, Lee CM, Son SY, Ahn SH, Park DJ, Kim HH, et al. Laparoscopic versus open gastrectomy for gastric cancer: long-term oncologic results. Surgery. 2014;155(1):154–64.CrossRef Lee JH, Lee CM, Son SY, Ahn SH, Park DJ, Kim HH, et al. Laparoscopic versus open gastrectomy for gastric cancer: long-term oncologic results. Surgery. 2014;155(1):154–64.CrossRef
8.
Zurück zum Zitat Kunisaki C, Akiyama H, Nomura M, Matsuda G, Otsuka Y, Ono HA, et al. Comparison of surgical outcomes of gastric cancer in elderly and middle-aged patients. Am J Surg. 2006;191(2):216–24.CrossRef Kunisaki C, Akiyama H, Nomura M, Matsuda G, Otsuka Y, Ono HA, et al. Comparison of surgical outcomes of gastric cancer in elderly and middle-aged patients. Am J Surg. 2006;191(2):216–24.CrossRef
9.
Zurück zum Zitat Chen J, Chen J, Xu Y, Long Z, Zhou Y, Zhu H, et al. Impact of age on the prognosis of operable gastric cancer patients: an analysis based on SEER database. Medicine (Baltimore). 2016;95(24):e3944.CrossRef Chen J, Chen J, Xu Y, Long Z, Zhou Y, Zhu H, et al. Impact of age on the prognosis of operable gastric cancer patients: an analysis based on SEER database. Medicine (Baltimore). 2016;95(24):e3944.CrossRef
10.
Zurück zum Zitat Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. New Engl J Med. 2008;359(5):453–62.CrossRef Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. New Engl J Med. 2008;359(5):453–62.CrossRef
11.
Zurück zum Zitat Fang C, Hua J, Li J, Zhen J, Wang F, Zhao Q, et al. Comparison of long-term results between laparoscopy-assisted gastrectomy and open gastrectomy with D2 lymphadenectomy for advanced gastric cancer. Am J Surg. 2014;208(3):391–6.CrossRef Fang C, Hua J, Li J, Zhen J, Wang F, Zhao Q, et al. Comparison of long-term results between laparoscopy-assisted gastrectomy and open gastrectomy with D2 lymphadenectomy for advanced gastric cancer. Am J Surg. 2014;208(3):391–6.CrossRef
12.
Zurück zum Zitat Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2017;20(1):1–19. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2017;20(1):1–19.
13.
Zurück zum Zitat Nakagawa N, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, et al. Pathological tumor infiltrative pattern and sites of initial recurrence in stage II/III gastric cancer: propensity score matching analysis of a multi-institutional dataset. Cancer Med. 2018;7(12):6020–9.CrossRef Nakagawa N, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, et al. Pathological tumor infiltrative pattern and sites of initial recurrence in stage II/III gastric cancer: propensity score matching analysis of a multi-institutional dataset. Cancer Med. 2018;7(12):6020–9.CrossRef
14.
Zurück zum Zitat Ryo S, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, et al. The controlling nutritional status score serves as a predictor of short- and long-term outcomes for patients with stage 2 or 3 gastric cancer: analysis of a multi-institutional data set. Ann Surg Oncol. 2019;26(2):456–64.CrossRef Ryo S, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, et al. The controlling nutritional status score serves as a predictor of short- and long-term outcomes for patients with stage 2 or 3 gastric cancer: analysis of a multi-institutional data set. Ann Surg Oncol. 2019;26(2):456–64.CrossRef
15.
Zurück zum Zitat Nakanishi K, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, et al. Delay in initiation of postoperative adjuvant chemotherapy with S-1 monotherapy and prognosis for gastric cancer patients: analysis of a multi-institutional dataset. Gastric Cancer. 2019;22(6):1215–25.CrossRef Nakanishi K, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, et al. Delay in initiation of postoperative adjuvant chemotherapy with S-1 monotherapy and prognosis for gastric cancer patients: analysis of a multi-institutional dataset. Gastric Cancer. 2019;22(6):1215–25.CrossRef
16.
Zurück zum Zitat Kanda M, Murotani K, Kobayashi D, Tanaka C, Yamada S, Fujii T, et al. Postoperative adjuvant chemotherapy with S-1 alters recurrence patterns and prognostic factors among patients with stage II/III gastric cancer: a propensity score matching analysis. Surgery. 2015;158(6):1573–80.CrossRef Kanda M, Murotani K, Kobayashi D, Tanaka C, Yamada S, Fujii T, et al. Postoperative adjuvant chemotherapy with S-1 alters recurrence patterns and prognostic factors among patients with stage II/III gastric cancer: a propensity score matching analysis. Surgery. 2015;158(6):1573–80.CrossRef
17.
Zurück zum Zitat Sasahara M, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, et al. The preoperative prognostic nutritional index predicts short-term and long-term outcomes of patients with stage II/III gastric cancer: analysis of a multi-institution dataset. Dig Surg 2020;37(2):135–44.CrossRef Sasahara M, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, et al. The preoperative prognostic nutritional index predicts short-term and long-term outcomes of patients with stage II/III gastric cancer: analysis of a multi-institution dataset. Dig Surg 2020;37(2):135–44.CrossRef
18.
Zurück zum Zitat Liu L, Bai Y, Gu H, Zhu H, Yu Y, Lu P, et al. The prognostic efficacy of the 8th edition UICC TNM classifications for gastric cancer in Chinese patients: a study based on follow-up system of nursing department. Medicine (Baltimore). 2018;97(36):e12284.CrossRef Liu L, Bai Y, Gu H, Zhu H, Yu Y, Lu P, et al. The prognostic efficacy of the 8th edition UICC TNM classifications for gastric cancer in Chinese patients: a study based on follow-up system of nursing department. Medicine (Baltimore). 2018;97(36):e12284.CrossRef
19.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.CrossRef Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.CrossRef
20.
Zurück zum Zitat Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11(5):439–49.CrossRef Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11(5):439–49.CrossRef
21.
Zurück zum Zitat Memon MA, Subramanya MS, Khan S, Hossain MB, Osland E, Memon B, et al. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma. Ann Surg. 2011;253(5):900–11.CrossRef Memon MA, Subramanya MS, Khan S, Hossain MB, Osland E, Memon B, et al. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma. Ann Surg. 2011;253(5):900–11.CrossRef
22.
Zurück zum Zitat Suzuki S, Kanaji S, Matsuda Y, Yamamoto M, Hasegawa H, Yamashita K, et al. Long-term impact of postoperative pneumonia after curative gastrectomy for elderly gastric cancer patients. Ann Gastroenterol Surg. 2018;2(1):72–8.CrossRef Suzuki S, Kanaji S, Matsuda Y, Yamamoto M, Hasegawa H, Yamashita K, et al. Long-term impact of postoperative pneumonia after curative gastrectomy for elderly gastric cancer patients. Ann Gastroenterol Surg. 2018;2(1):72–8.CrossRef
23.
Zurück zum Zitat Wang S, Xu L, Wang Q, Li J, Bai B, Li Z, et al. Postoperative complications and prognosis after radical gastrectomy for gastric cancer: a systematic review and meta-analysis of observational studies. World J Surg Oncol. 2019;17(1):52.CrossRef Wang S, Xu L, Wang Q, Li J, Bai B, Li Z, et al. Postoperative complications and prognosis after radical gastrectomy for gastric cancer: a systematic review and meta-analysis of observational studies. World J Surg Oncol. 2019;17(1):52.CrossRef
24.
Zurück zum Zitat Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, et al. Multi-institutional analysis of the prognostic significance of postoperative complications after curative resection for gastric cancer. Cancer Med. 2019;8(11):5194–201.CrossRef Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, et al. Multi-institutional analysis of the prognostic significance of postoperative complications after curative resection for gastric cancer. Cancer Med. 2019;8(11):5194–201.CrossRef
25.
Zurück zum Zitat Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. New Engl J Med. 2007;357(18):1810–20.CrossRef Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. New Engl J Med. 2007;357(18):1810–20.CrossRef
26.
Zurück zum Zitat Yang W, Hu R, Li GC, Zhou ML, Wang Y, Shen LJ, et al. Survival outcomes and patterns of failure after D2 dissection and adjuvant chemoradiotherapy for locally advanced gastric cancer: a retrospective study. Br J Radiol. 2018;91(1089):20170594.CrossRef Yang W, Hu R, Li GC, Zhou ML, Wang Y, Shen LJ, et al. Survival outcomes and patterns of failure after D2 dissection and adjuvant chemoradiotherapy for locally advanced gastric cancer: a retrospective study. Br J Radiol. 2018;91(1089):20170594.CrossRef
27.
Zurück zum Zitat Sasako M, Sakuramoto S, Katai H, Kinoshita T, Furukawa H, Yamaguchi T, et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol. 2011;29(33):4387–93.CrossRef Sasako M, Sakuramoto S, Katai H, Kinoshita T, Furukawa H, Yamaguchi T, et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol. 2011;29(33):4387–93.CrossRef
28.
Zurück zum Zitat Bennett-Guerrero E, Hyam JA, Shaefi S, Prytherch DR, Sutton GL, Weaver PC et al. Comparison of P-POSSUM risk-adjusted mortality rates after surgery between patients in the USA and the UK. Br J Surg. 2003;90(12):1593–8.CrossRef Bennett-Guerrero E, Hyam JA, Shaefi S, Prytherch DR, Sutton GL, Weaver PC et al. Comparison of P-POSSUM risk-adjusted mortality rates after surgery between patients in the USA and the UK. Br J Surg. 2003;90(12):1593–8.CrossRef
Metadaten
Titel
D2 lymph node dissection confers little benefit on the overall survival of older patients with resectable gastric cancer: a propensity score-matching analysis of a multi-institutional dataset
verfasst von
Takahiro Shinozuka
Mitsuro Kanda
Seiji Ito
Yoshinari Mochizuki
Hitoshi Teramoto
Kiyoshi Ishigure
Toshifumi Murai
Takahiro Asada
Akiharu Ishiyama
Hidenobu Matsushita
Chie Tanaka
Daisuke Kobayashi
Michitaka Fujiwara
Kenta Murotani
Yasuhiro Kodera
Publikationsdatum
25.05.2020
Verlag
Springer Singapore
Erschienen in
Surgery Today / Ausgabe 11/2020
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-020-02021-7

Weitere Artikel der Ausgabe 11/2020

Surgery Today 11/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.